An economic evaluation of trastuzumab as adjuvant treatment of early HER2-positive breast cancer patients in Colombia

Objective: Trastuzumab (Herceptin®), a recombinant, humanized, monoclonal antibody targeting HER2 is well established as an effective treatment for HER2-positive breast cancer. Evidence from developed countries showed that trastuzumab was cost-effective; but there are few evidences in developing cou...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Biomédica
Main Authors: Jefferson Antonio Buendía, Carlos Vallejos, Andrés Pichón-Rivière
Format: Artigo
Sprog:Inglês
Udgivet: Instituto Nacional de Salud 2013
Fag:
Medicina
Positive
Colombia
Breast cancer
Human Epidermal Growth Factor Receptor 2
Online adgang:https://www.redalyc.org/articulo.oa?id=84329151010
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker